Navigation Links
Yongye Biotechnology International Announces Second Quarter Results
Date:8/18/2008

etwork in the second quarter of 2008, bringing the total number of such stores through which the Company distributes its products to 775 by the end of the quarter. The Company had 200 stores at the end of 2007. The Company and its local distributor approach existing agricultural product store owners to contract with them and bring them into the Yongye branded store network.

Gross profit was $9.6 million in the second quarter of 2008, an increase of 171.8% from $3.5 million in the second quarter of 2007. Gross margin rose to 54.6% from 47.5% in the second quarter of 2007. Gross margin increased because of cost efficiencies resulting from increased production and more stable product prices.

Selling expenses were $777,012 in the second quarter of 2008, compared to $62,135 in the second quarter of 2007. Selling expenses increased because of rapidly adding new sales people and a proportionate increase in expenses associated with a dramatic increase in sales volume. General and administrative expenses were $454,697 in the second quarter of 2008, compared to $108,350 in the second quarter of 2007. General and administrative expenses grew because of adding new executive staff and new expenses associated with becoming a public company.

Operating income was $8.4 million in the second quarter of 2008, with operating margin of 47.6%, compared to $3.4 million in the second quarter of 2007, with operating margin 45.2%.

Net income was $7.2 million in the second quarter of 2008, or $0.41 per diluted share, compared to net income of $3.3 million, or $0.29 per diluted share, in the second quarter of 2007.

The diluted weighted average number of shares outstanding increased from 11,444,775 in the second quarter of 2007 to 17,435,896 in the second quarter of 2008 because additional shares were issued in the private placement which took place in April 2008.

Six Months 2008 Results

Net revenue was $27.0 million in the six months ended June
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... , ... The 2015 Market Research Report on the Global Propanol Industry ... Propanol market with a focus on the Chinese situation. Major companies included in the ... Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... The American Botanical Council (ABC) has announced the recipient ... Award in the reference and technical book category. The ... Botanical Medicines (CRC Press, 2011), has been chosen ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The ABC James A. ...
... equipment, capable of generating intense pulses of light as short ... Red, will help scientists at the University of East Anglia ... and point the way to molecular structures for exploiting solar ... Engineering and Physical Sciences Research Council, the new laser will ...
... Feb. 28, 2012 Regado Biosciences, Inc., a privately held ... agents, announced that David J. Mazzo, PhD, President and CEO, ... Annual Health Care Conference at 1:30 p.m. EST on ... Boston, MA.  The presentation will include an ...
Cached Biology Technology:Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 2Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 3Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 4Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 5New laser can point the way to new energy harvesting 2Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA 2Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA 3
(Date:7/21/2015)... 21, 2015 Passwords have proven futile ... the recent U.S. Office of Personnel Management breach. ... infosec conundrum, but developers and end-users are concerned ... this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today ... for third party integration. A ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... N.C. By altering the genetic makeup of normally ... cells capable of generating and passing electrical current. ... treating diseases of the nervous system or the heart, ... to communicate with adjacent cells in order to function ...
... gene therapy into an arterial wall effectively protects the ... The promising results, published July 19 in the journal ... In atherosclerosis, fatty lesions called plaques form ... narrows arteries, thereby restricting blood flow and causing chest ...
... and Providence cities scattered across the eastern half ... all have coal-fired power plants. A new study from ... is among the first to investigate mercury deposits in ... The study, which appears in the July 2011 issue ...
Cached Biology News:Engineering excitable cells for studies of bioelectricity and cell therapy 2Engineering excitable cells for studies of bioelectricity and cell therapy 3Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 2Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 3Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies 4Soil samples reveal urban mercury footprints 2
... a novel disposable spin filtration device especially ... lysates in plasmid purification procedures. , ... spin filtration device especially designed to aid ... purification procedures. The neutralized lysate is centrifuged ...
... any standard fixed-angle microcentrifuge rotor at ... centrifuge tube filters consist of a ... tube. They filter by centrifugation for ... preparation, removal of cells from media ...
... in any standard fixed-angle microcentrifuge rotor ... g.,Spin- centrifuge tube filters consist of ... centrifuge tube. They filter by centrifugation ... sample preparation, removal of cells from ...
HybriWell seals securely to a microscope slide surface in seconds to enclose single or multiple specimens in a small reagent volume and eliminate evaporation....
Biology Products: